Summary
Contraceptive requirements applied to women of child-bearing potential participating in clinical trials also apply to children participating in pediatric clinical trials, creating significant challenges for sponsors, parents, investigators and study staff.
Register to download
The Impact Of Contraceptive Requirements On Pediatric Clinical Trials
You may also be interested in:
Blog
Looking Forward: COVID-19 Treatments, Vaccines, and Distribution
COVID-19 will have both short-term and long-term impacts on society—many of which we’re already seeing today. With the number of cases multiplying,…
Read Story
Blog
Janssen Pharmaceuticals and PRA Health Sciences Launch First Fully Virtual Trial for Heart Failure Drug Approval
Janssen Pharmaceuticals and PRA Health Launch First Fully Virtual Trial for Heart Failure Drug Approval. Healthcare giant Janssen Pharmaceuticals and…
Read Story
Blog
PRA Talks COVID-19 Impact on Rare Disease Clinical Trials with Patient Advocates
PRA’s Center for Rare Diseases understands that clinical trials are both a source of hope and care for people affected by a rare disease. The impact…
Read Story
View all related content and resources for Clinical Development
Explore Insights